Showing 1171-1180 of 1206 results for "".
- FDA Clears Lutronic Genius Platform for RF Microneedlinghttps://modernaesthetics.com/news/fda-clears-lutronic-genius-platform-for-rf-microneedling/2471952/Lutronic has received FDA clearance of the Lutronic Genius™ platform for radiofrequency microneedling. The company says the device transmits energy more precisely into the skin. The Lutronic Intelligent Care™products incorp
- First Patients Treated in Pulse Biosciences' Sebaceous Hyperplasia Studyhttps://modernaesthetics.com/news/first-patients-treated-in-pulse-biosciences-sebaceous-hyperplasia-study/2472061/Pulse Biosciences, Inc. says the first patients have been treated in its multi-center study to evaluate the safety and efficacy of its Nano-Pulse Stimulation (NPS) technology for eliminating Sebaceous Hyperplasia (SH). SH is an unsightly benign skin lesion that typically appears on facial skin an
- InMode Launches Triton Multi-Wavelength Hair Removal Laserhttps://modernaesthetics.com/news/inmode-launches-triton-multi-wavelength-hair-removal-laser/2472069/InMode Ltd. is launching the Triton hair removal device. Recently cleared by the FDA, Triton is the first and only high power laser to offer simultaneous multi-wavelength hair removal firing, allowing concurrent emissions of Alexandrite, Diode, and Nd:YAG wavelengths. The company say
- Cynosure Hires Katie Cheng As New CMOhttps://modernaesthetics.com/news/cynosure-hires-katie-cheng-as-new-chief-marketing-office/2473038/Katie Cheng is Cynosure’s new Chief Marketing Officer. "Katie's proven track record of consumer and professional marketing strategy and execution is one of the many reasons we are eager to have Katie join our team," says Cynosure CEO Todd Tillemans, i
- It's Camp Time for Dermatologistshttps://modernaesthetics.com/news/its-camp-time-for-dermatologists/2473432/As kids across the country got ready for summer camp, dermatologists flocked to Brooklyn, NY, for their own version of summer camp: Neutrogena’s immersive SkinU Summer Camp. Instead of learning to swim, sliding down a zipline, or playing tennis like kids in camp oft
- Industry Responds to COVID-19: Galderma, Timeless Skin Care, UCBhttps://modernaesthetics.com/news/industry-responds-to-covid-19-galderma-timeless-skin-care-ucb/2472915/Galderma. Galderma is offering educational webinars to support aesthetic customers during the pandemic. Galderma Italy donated Cetaphil hydrating lotion to hospitals and are also set to
- Sinclair North America Introduces Inaugural Advisory Boardhttps://modernaesthetics.com/news/sinclair-north-america-introduces-inaugural-advisory-board/2475577/Sinclair North America announced its inaugural Advisory Board, consisting of 16 plastic surgeons, dermatologists, aesthetic practitioners, and aestheticians. The board will advance Sinclair North America’s mission of delivering a timeless and trending portfolio of clinically-validated prod
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glu
- Teoxane Launches Consumer Access to Dermocosmetic Skincare Line in U.S.https://modernaesthetics.com/news/teoxane-launches-consumer-access-to-dermocosmetic-skincare-line-in-us/2475362/Teoxane has announced the U.S. launch of its dermocosmetics line, making its clinically developed skincare products available directly to consumers for the first time through its new online platform, teoxane.us. Previously offered exclusively through aesthetic professionals, the Swiss c
- Study Backs CP-GEP Tests’ Accuracyhttps://modernaesthetics.com/news/study-backs-cp-gep-tests-accuracy/2473699/Patients with clinically node-negative primary cutaneous melanoma undergoing sentinel lymph node biopsies (SLNBs) who were classified as “high risk” according to CP-GEP tests were approximately three times more likely to be SLN positive, according to data presented October 13 at the S